MRK241122P109000
- 9.55
- 0.000.00%
Merck & Co Newsroom
Trump Picks Surgeon Makary to Head FDA, Rep. Dave Weldon to Lead CDC
Merck Recommends Rejection Of TRC Capital's "Mini-Tender" Offer To Purchase Up To 1M Shares Of Common Stock At $96.38 Per Share
Express News | Merck Recommends Rejection of Trc Capital’s “Mini-Tender” Offer
Merck & Co. Expands Board With New Director
Jefferies Adjusts Price Target on Merck to $149 From $148, Maintains Buy Rating
Dividend Roundup: General Mills, Halliburton, Johnson & Johnson, Coca-Cola, and Others
Investors Heavily Search Merck & Co., Inc. (MRK): Here Is What You Need to Know
Market Chatter: Merck Asthma Drug Singulair Reportedly Linked to Psychiatric Problems in FDA Study
Merck Adds Emerson Electric Chief Executive to Its Board
Express News | Merck’s Welireg® (Belzutifan) Approved in China for the Treatment of Adult Patients With Certain Types of Von Hippel-Lindau (Vhl) Disease-Associated Tumors
Express News | Merck & Co Inc - Board to Consist of 13 Members With Karsanbhai
Express News | Surendralal Karsanbhai Elected to Merck Board of Directors
Goldman Sachs: Merck & Co., Inc. (MRK) Is A Top Growth Investor Stock
Optimism Over Global Healthcare Sector Rises: Jefferies
Citi Research's U.S. Equity Strategy Large-Cap Recommendation List
Pyxis Stock Craters 46% Amid Phase 1 Data, William Blair Downgrade
Pyxis Oncology's Cancer Drug Progress Stirs Analyst Concerns
Express News | Merck Data at the Ash 2024 Annual Meeting Highlights Promising Hematology Pipeline With Diverse Range of Investigational Assets and Novel Modalities
Vaccinated and Loved: Petco Love Distributes 3 Millionth Free Pet Vaccine
Merck & Co To Present At Jefferies London Healthcare Conference; Webcast At 6:30 AM ET